Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Pink

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Small (Weinheim an Der Bergstrasse, Germany)|January 17, 2026
Proteomic Profiling of Alveolar Macrophages Identifies Loss of Lysosomal Content as an Indicator of Nanofiber-Induced Frustrated PhagocytosisTobias Stobernack, Antje Vennemann, Carla Ribalta, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 20, 2023
Meta-Analysis of Integrated Proteomic and Transcriptomic Data Discerns Structure-Activity Relationship of Carbon Materials with Different MorphologiesVerónica I Dumit, Yuk-Chien Liu, Aileen Bahl, et al.
Amino Acids|February 27, 2015
New insights into novel inhibitors against deoxyhypusine hydroxylase from plasmodium falciparum: compounds with an iron chelating potentialImke von Koschitzky, Heike Gerhardt, Michael Lämmerhofer, et al.
Bioorganic & Medicinal Chemistry|June 10, 2014
Target evaluation of deoxyhypusine synthase from Theileria parva the neglected animal parasite and its relationship to PlasmodiumJames T Njuguna, Imke von Koschitzky, Heike Gerhardt, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 2011
A novel mechanism involved in the pathogenesis of Graves ophthalmopathy (GO): clathrin is a possible targeting molecule for inhibiting local immune response in the orbitMelissa Meyer zu Hörste, Elena Ströher, Utta Berchner-Pfannschmidt, et al.
Plos One|March 19, 2013
Deoxyhypusine hydroxylase from Plasmodium vivax, the neglected human malaria parasite: molecular cloning, expression and specific inhibition by the 5-LOX inhibitor zileutonVeronika Anyigoh Atemnkeng, Mario Pink, Simone Schmitz-Spanke, et al.
Nanoimpact|May 13, 2022
How can we justify grouping of nanoforms for hazard assessment? Concepts and tools to quantify similarityNina Jeliazkova, Eric Bleeker, Richard Cross, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Small (Weinheim an Der Bergstrasse, Germany)|January 17, 2026
Proteomic Profiling of Alveolar Macrophages Identifies Loss of Lysosomal Content as an Indicator of Nanofiber-Induced Frustrated PhagocytosisTobias Stobernack, Antje Vennemann, Carla Ribalta, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 20, 2023
Meta-Analysis of Integrated Proteomic and Transcriptomic Data Discerns Structure-Activity Relationship of Carbon Materials with Different MorphologiesVerónica I Dumit, Yuk-Chien Liu, Aileen Bahl, et al.
Amino Acids|February 27, 2015
New insights into novel inhibitors against deoxyhypusine hydroxylase from plasmodium falciparum: compounds with an iron chelating potentialImke von Koschitzky, Heike Gerhardt, Michael Lämmerhofer, et al.
Bioorganic & Medicinal Chemistry|June 10, 2014
Target evaluation of deoxyhypusine synthase from Theileria parva the neglected animal parasite and its relationship to PlasmodiumJames T Njuguna, Imke von Koschitzky, Heike Gerhardt, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 2011
A novel mechanism involved in the pathogenesis of Graves ophthalmopathy (GO): clathrin is a possible targeting molecule for inhibiting local immune response in the orbitMelissa Meyer zu Hörste, Elena Ströher, Utta Berchner-Pfannschmidt, et al.
Plos One|March 19, 2013
Deoxyhypusine hydroxylase from Plasmodium vivax, the neglected human malaria parasite: molecular cloning, expression and specific inhibition by the 5-LOX inhibitor zileutonVeronika Anyigoh Atemnkeng, Mario Pink, Simone Schmitz-Spanke, et al.
Nanoimpact|May 13, 2022
How can we justify grouping of nanoforms for hazard assessment? Concepts and tools to quantify similarityNina Jeliazkova, Eric Bleeker, Richard Cross, et al.
Pageof 3